• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同侧乳腺肿瘤复发的多灶性——消融标本研究。

Multifocality in ipsilateral breast tumor recurrence - A study in ablative specimens.

机构信息

Department of Surgery, Catharina Hospital Eindhoven, the Netherlands.

Department of Surgery, Catharina Hospital Eindhoven, the Netherlands.

出版信息

Eur J Surg Oncol. 2020 Aug;46(8):1471-1476. doi: 10.1016/j.ejso.2020.04.035. Epub 2020 Apr 23.

DOI:10.1016/j.ejso.2020.04.035
PMID:32402507
Abstract

BACKGROUND

The incidence and clinical significance of multifocality in ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy (BCT) are unclear. With growing interest in repeat BCT, this information has become of importance. This study aimed to gain insight in the incidence of multifocality in IBTR, to identify patient- and tumor-related predicting factors and to investigate the prognostic significance of multifocality.

METHODS

Two hundred and fifteen patients were included in this analysis. All had an IBTR after BCT and were treated by salvage mastectomy and appropriate adjuvant therapy. Predictive tumor- and patient-related factors for multifocality in IBTR were identified using X2 test and univariate logistic regression analyses. Prognostic outcomes were calculated using Kaplan Meier analysis and compared using the log rank test.

RESULTS

Multifocality was present in 50 (22.9%) of IBTR mastectomy specimens. Axillary positivity in IBTR was significantly associated with multifocality in IBTR. Chest wall re-recurrences occurred more often after multifocal IBTR (14% versus 7% after unifocal IBTR, p = 0.120). Regional re-recurrences did not differ significantly between unifocal and multifocal IBTR (8% vs. 6%, p = 0.773). Distant metastasis after salvage surgery occurred more frequently after multifocal IBTR (15% vs. 24%, p = 0.122). Overall survival was 132 months after unifocal IBTR and 112 months after multifocal IBTR (p = 0.197).

CONCLUSION

The prevalence of multifocality in IBTR is higher than in primary breast cancer. Axillary positivity in IBTR was associated with a multifocal IBTR. Chest wall re-recurrences and distant metastasis were, although not statistically significant, more prevalent after multifocal IBTR.

摘要

背景

保乳治疗(BCT)后同侧乳房肿瘤复发(IBTR)的多灶性的发生率和临床意义尚不清楚。随着对重复 BCT 兴趣的增加,这些信息变得越来越重要。本研究旨在深入了解 IBTR 多灶性的发生率,确定与患者和肿瘤相关的预测因素,并探讨多灶性的预后意义。

方法

本分析纳入了 215 例患者。所有患者均在 BCT 后发生 IBTR,并接受挽救性乳房切除术和适当的辅助治疗。使用 X2 检验和单因素逻辑回归分析确定与 IBTR 多灶性相关的预测性肿瘤和患者相关因素。使用 Kaplan-Meier 分析计算预后结果,并使用对数秩检验进行比较。

结果

50 例(22.9%)IBTR 乳房切除标本存在多灶性。IBTR 中的腋窝阳性与 IBTR 中的多灶性显著相关。多灶性 IBTR 后更常发生胸壁再复发(14%比单灶性 IBTR 的 7%,p=0.120)。多灶性和单灶性 IBTR 之间的区域再复发无显著差异(8%比 6%,p=0.773)。挽救手术后远处转移在多灶性 IBTR 后更频繁发生(15%比 24%,p=0.122)。单灶性 IBTR 后的总生存时间为 132 个月,多灶性 IBTR 后的总生存时间为 112 个月(p=0.197)。

结论

IBTR 多灶性的发生率高于原发性乳腺癌。IBTR 中的腋窝阳性与 IBTR 的多灶性相关。尽管无统计学意义,但多灶性 IBTR 后胸壁再复发和远处转移更常见。

相似文献

1
Multifocality in ipsilateral breast tumor recurrence - A study in ablative specimens.同侧乳腺肿瘤复发的多灶性——消融标本研究。
Eur J Surg Oncol. 2020 Aug;46(8):1471-1476. doi: 10.1016/j.ejso.2020.04.035. Epub 2020 Apr 23.
2
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.基于真性复发和新发原发性肿瘤分类的保乳治疗后同侧乳腺肿瘤复发分析
Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104.
3
[Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].保乳治疗后同侧乳腺肿瘤复发患者的临床特征与预后
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):352-358. doi: 10.3760/cma.j.issn.0253-3766.2018.05.007.
4
Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.接受新辅助化疗后接受保乳治疗的可手术乳腺癌患者同侧乳房肿瘤复发(IBTR):IBTR 的危险因素和 MD 安德森预后指数的验证。
Cancer. 2012 Sep 15;118(18):4385-93. doi: 10.1002/cncr.27377. Epub 2012 Jan 17.
5
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
6
Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?多灶性回归是否为新辅助化疗和保乳治疗后现代时代同侧乳腺癌复发的危险因素?
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):869-876. doi: 10.1016/j.ijrobp.2019.03.012. Epub 2019 Mar 15.
7
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.
8
Local recurrence risk after previous salvage mastectomy.既往挽救性乳房切除术后的局部复发风险。
Eur J Surg Oncol. 2016 Jul;42(7):980-5. doi: 10.1016/j.ejso.2016.03.008. Epub 2016 Mar 26.
9
Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.重复保乳疗法治疗同侧乳腺癌复发:一项系统评价。
Eur J Surg Oncol. 2019 Aug;45(8):1317-1327. doi: 10.1016/j.ejso.2019.02.008. Epub 2019 Feb 10.
10
Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.同侧乳腺癌复发患者乳房切除术后与再次肿块切除术后的预后:一项倾向评分分析。
Eur J Surg Oncol. 2016 Apr;42(4):474-80. doi: 10.1016/j.ejso.2016.01.011. Epub 2016 Jan 22.

引用本文的文献

1
Residual Risk of Ipsilateral Tumor Recurrence in Patients Who Achieved Clear Lumpectomy Margins After Repeated Resection.经反复切除后切缘阴性的患者同侧肿瘤复发的残留风险
J Breast Cancer. 2023 Dec;26(6):558-571. doi: 10.4048/jbc.2023.26.e46. Epub 2023 Oct 17.
2
A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancer.用于预测 T1-2HR+ 乳腺癌非前哨淋巴结转移的多维列线图。
Front Endocrinol (Lausanne). 2023 Jul 5;14:1121394. doi: 10.3389/fendo.2023.1121394. eCollection 2023.